RNTX
Rein Therapeutics, Inc.
Company overview
- Market capitalization
- $62.20M
- Employees
- 10
- Latest publication
- 2026-09-29
About Rein Therapeutics, Inc.
Rein Therapeutics Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States. The company's lead product candidate is LTI-03, a peptide, which is in Phase 2 clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). It also offers LTI-01, a proenzyme that has completed Phase 1b and Phase 2a clinical trials in LPE patients for the treatment of loculated pleural effusion. The company's pipeline also includes preclinical programs targeting cystic fibrosis and a peptide program focused on the caveolin-1 protein for systemic fibrosis indications; and LTI-05, an epithelial sodium channel, which is in preclinical trial phase for the treatment of cystic fibrosis. The company was formerly known as Aileron Therapeutics, Inc. and changed its name to Rein Therapeutics Inc. in February 2007. The company was incorporated in 2001 and is headquartered in Austin, Texas.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Research Development | 3,638,000USD | 3,073,000USD | 2,002,000USD | 1,681,000USD | 4,292,000USD | 3,054,000USD | 3,322,000USD | 3,722,000USD |
| Selling General Administrative | 2,438,000USD | 2,157,000USD | 1,958,000USD | 3,811,000USD | 2,579,000USD | 2,555,000USD | 2,475,000USD | 2,349USD |
| General And Administrative Expenses | 2,438,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 6,076,000USD | 5,230,000USD | 3,959,000USD | 5,492,000USD | 6,871,000USD | 5,609,000USD | 42,797,000USD | 6,071,000USD |
| Operating Income | -6,076,000USD | -5,230,000USD | -3,959,000USD | -5,492,000USD | -6,871,000USD | -5,609,000USD | -42,797,000USD | -6,071,000USD |
| Total Other Income Expense Net | -299,000USD | -608,000USD | -28,720,000USD | -89,000USD | 49,000USD | 108,000USD | 272,000USD | 224,000USD |
| Net Income | -6,375,000USD | -5,838,000USD | -31,967,000USD | -5,581,000USD | -6,822,000USD | -5,501,000USD | -40,981,000USD | -5,847,000USD |
| Income Before Tax | — | -5,838,000USD | -32,679,000USD | -5,581,000USD | -6,822,000USD | -5,501,000USD | -42,410,000USD | -5,847,000USD |
| Net Income From Continuing Ops | — | -5,838,000USD | -31,967,000USD | -5,581,000USD | -6,822,000USD | -5,501,000USD | -40,866,000USD | -5,847,000USD |
| Ebitda | — | -5,230,000USD | -3,870,000USD | -5,492,000USD | -6,870,000USD | -5,609,000USD | -5,797USD | -5,847,000USD |
| Income Tax Expense | — | — | -712,000USD | — | — | -1,544,000USD | 1,544USD | — |
| Ebit | — | — | -32,570,000USD | — | -6,871,000USD | -5,797,000USD | -5,797,000USD | 5,722,195USD |
| Depreciation And Amortization | — | — | -1,000USD | — | 1,000USD | 5,791,203USD | 5,791,203USD | -5,728,266USD |
| Reconciled Depreciation | — | — | 0USD | 0USD | 1,000USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | — | — | — | — | 1,000USD | — | — | — |
| Gross Profit | — | — | — | — | -1,000USD | — | — | — |
| Selling And Marketing Expenses | — | — | — | — | — | — | 2,472,525USD | — |
| Unclassified Operating Expenses | — | — | — | — | — | — | 34,527,475USD | 2,346,651USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 1,000USD | 63,000USD | — | — | — | — |
| Gross Profit | -1,000USD | -63,000USD | — | — | — | — |
| Research Development | 11,029,000USD | 14,248,000USD | 3,991USD | 17,967USD | 17,008USD | 11,166USD |
| Selling General Administrative | 10,902,000USD | 13,864,000USD | 11,357USD | 9,680USD | 9,597USD | 9,330USD |
| Total Operating Expenses | 21,930,000USD | 65,112,000USD | 16,276USD | 27,647USD | 26,605USD | 20,496USD |
| Operating Income | -21,931,000USD | -65,112,000USD | -16,276USD | -27,647USD | -26,605USD | -20,496USD |
| Income Before Tax | -50,583,000USD | -64,312,000USD | -15,732USD | -27,329USD | -26,164USD | -21,157USD |
| Income Tax Expense | -712,000USD | -1,544,000USD | — | — | — | — |
| Tax Provision | -712,000USD | -1,544,000USD | 0USD | — | — | — |
| Net Income | -49,871,000USD | -62,883,000USD | -15,732USD | -27,329USD | -26,164USD | -21,157USD |
| Net Income From Continuing Ops | -49,871,000USD | -62,768,000USD | -15,676,000USD | -27,329,000USD | -26,164,000USD | -21,196,000USD |
| Ebit | -21,931,000USD | -28,112,000USD | -15,348USD | -27,647USD | -26,605USD | -20,496USD |
| Ebitda | -21,930,000USD | -28,049,000USD | -15,229USD | -27,478USD | -26,484USD | -20,333USD |
| Depreciation And Amortization | 1,000USD | 63,000USD | 119USD | 169USD | 121USD | 163USD |
| Reconciled Depreciation | 1,000USD | 63,000USD | 119,000USD | 169,000USD | 121,000USD | 163,000USD |
| Total Other Income Expense Net | -28,652,000USD | 800,000USD | 544USD | 318USD | 441USD | -661USD |
| Selling And Marketing Expenses | — | 13,850,136USD | — | — | — | — |
| Unclassified Operating Expenses | — | 23,149,864USD | — | — | — | — |
| Interest Income | — | 400,000USD | 400,000USD | 300,000USD | — | — |
| Net Interest Income | — | 400,000USD | 400,000USD | 300,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 65,973,000USD | 26,288,000USD | 24,158,000USD | 53,706,000USD | 57,479,000USD | 57,628,000USD | 62,190,000USD | 104,217,000USD |
| Cash And Equivalents | 8,542,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 40,647,000USD | 4,445,000USD | 3,215,000USD | 4,048,000USD | 5,722,000USD | 7,428,000USD | 12,865,000USD | 17,652,000USD |
| Short Term Investments | 32,105,000USD | — | — | — | — | — | — | — |
| Long Term Investments | 2,980,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 41,453,000USD | 5,453,000USD | 4,326,000USD | 5,174,000USD | 6,602,000USD | 8,331,000USD | 13,657,000USD | 18,684,000USD |
| Other Current Assets | 727,000USD | 1,008,000USD | 1,111,000USD | 1,126,000USD | 880,000USD | 903,000USD | 792,000USD | 1,032,000USD |
| Other Non Current Assets | 1,710,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 10,769,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 9,709,000USD | 13,637,000USD | 6,180,000USD | 5,744,000USD | 7,694,000USD | 5,977,000USD | 5,749,000USD | 5,659,000USD |
| Total Stockholder Equity | 55,204,000USD | 11,591,000USD | 16,918,000USD | 46,190,000USD | 3,008,000USD | 4,874,000USD | 54,392,000USD | 50,227,000USD |
| Total Equity Including Noncontrolling Interest | 55,204,000USD | — | — | — | — | — | — | — |
| Goodwill | 6,330,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 13,500,000USD | 13,500,000USD | 13,500,000USD | 42,200,000USD | 42,200,000USD | 42,200,000USD | 42,200,000USD | 79,200,000USD |
| Accounts Payable | 4,466,000USD | 6,263,000USD | 3,976,000USD | 4,123,000USD | 6,028,000USD | 1,149,000USD | 911,000USD | 1,079,000USD |
| Common Stock | 172,000USD | 114,000USD | 113,000USD | 111,000USD | 131,000USD | 108,000USD | 108,000USD | 108,000USD |
| Retained Earnings | -413,484,000USD | -407,109,000USD | -401,271,000USD | -369,304,000USD | -363,723,000USD | -356,901,000USD | -351,400,000USD | -310,419,000USD |
| Accumulated Other Comprehensive Income | -69,000USD | -62,000USD | -62,000USD | -44,000USD | -44,000USD | -32,000USD | -18,000USD | -26,000USD |
| Total Liab | — | 14,697,000USD | 7,240,000USD | 7,516,000USD | 54,471,000USD | 52,754,000USD | 7,798,000USD | 53,990,000USD |
| Other Current Liab | — | 2,451,000USD | 2,204,000USD | 1,621,000USD | 1,666,000USD | 4,828,000USD | 4,838,000USD | 4,580,000USD |
| Capital Stock | — | 114,000USD | 113,000USD | 111,000USD | 131,000USD | 108,000USD | 108,000USD | 108,000USD |
| Good Will | — | 6,330,000USD | 6,330,000USD | 6,330,000USD | 6,330,000USD | 6,330,000USD | 6,330,000USD | 6,330,000USD |
| Cash | — | 4,445,000USD | 3,215,000USD | 4,048,000USD | 5,722,000USD | 7,428,000USD | 12,865,000USD | 17,652,000USD |
| Net Debt | — | 478,000USD | -3,215,000USD | -4,048,000USD | -5,722,000USD | -7,428,000USD | -12,865,000USD | -17,652,000USD |
| Short Term Debt | — | 4,923,000USD | — | — | — | — | — | — |
| Short Long Term Debt | — | 4,923,000USD | — | — | — | — | — | — |
| Short Long Term Debt Total | — | 4,923,000USD | — | — | — | — | — | — |
| Common Stock Shares Outstanding | — | 30,354,647shares | 25,444,795shares | 26,361,386shares | 24,187,536shares | 22,940,268shares | 21,693shares | 21,663,000shares |
| Non Current Assets Total | — | 20,835,000USD | 19,832,000USD | 48,532,000USD | 50,877,000USD | 49,297,000USD | 48,533,000USD | 85,533,000USD |
| Non Current Liabilities Total | — | 1,060,000USD | 1,060,000USD | 1,772,000USD | 46,777,000USD | 46,777,000USD | 47,054,000USD | 48,331,000USD |
| Non Currrent Assets Other | — | 1,005,000USD | 2,000USD | 2,000USD | 2,346,000USD | 766,000USD | 2,000USD | 2,000USD |
| Net Working Capital | — | -8,184,000USD | -1,854,000USD | -570,000USD | -1,092,000USD | 2,354,000USD | 7,908,000USD | 13,025,000USD |
| Unclassified Current Liabilities | — | -4,923,000USD | — | — | — | — | — | — |
| Unclassified Non Current Liabilities | — | 1,060,000USD | 1,060,000USD | 1,772,000USD | 46,777,000USD | 46,777,000USD | 46,777,000USD | 48,331,000USD |
| Unclassified Equity | — | 418,534,000USD | 418,025,000USD | 415,316,000USD | 366,513,000USD | 361,591,000USD | 405,594,000USD | 360,456,000USD |
| Property Plant Equipment Net | — | — | 0USD | 0USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD |
| Non Current Liabilities Other | — | — | — | — | — | — | 277,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 24,158,000USD | 69,240,000USD | 106,008,000USD | 22,007,000USD | 48,481,000USD | 16,341,000USD | 26,473,000USD | 30,312,000USD |
| Intangible Assets | 13,500,000USD | 48,530,000USD | 79,200,000USD | — | — | — | — | — |
| Other Current Assets | 1,111,000USD | 792,000USD | 953,000USD | 631,000USD | 2,244,000USD | 2,521,000USD | 1,272,000USD | 1,080,000USD |
| Total Liab | 7,240,000USD | 14,848,000USD | 99,121,000USD | 3,384,000USD | 4,577,000USD | 4,179,000USD | 10,425,000USD | 10,712,000USD |
| Total Stockholder Equity | 16,918,000USD | 54,392,000USD | 6,887,000USD | 18,623,000USD | 43,904,000USD | 12,162,000USD | 16,048,000USD | 19,600,000USD |
| Other Current Liab | 2,204,000USD | 4,838,000USD | 3,147,000USD | 1,631,000USD | 3,205,000USD | 2,196,000USD | 3,941,000USD | 3,639,000USD |
| Common Stock | 113,000USD | 108,000USD | 91,000USD | 91,000USD | 91,000USD | 44,000USD | 28,000USD | 15,000USD |
| Capital Stock | 113,000USD | 108,000USD | 91,000USD | 91,000USD | 91,000USD | 44,000USD | — | — |
| Retained Earnings | -401,271,000USD | -351,400,000USD | -288,517,000USD | -272,785,000USD | -245,456,000USD | -219,292,000USD | -198,135,000USD | -168,493,000USD |
| Good Will | 6,330,000USD | 6,330,000USD | 6,330,000USD | 0USD | — | — | — | — |
| Cash | 3,215,000USD | 12,865,000USD | 17,313,000USD | 5,194,000USD | 3,600,000USD | 7,046,000USD | 5,311,000USD | 10,635,000USD |
| Cash And Short Term Investments | 3,215,000USD | 12,865,000USD | 17,313,000USD | 21,242,000USD | 45,933,000USD | 13,805,000USD | 18,278,000USD | 20,695,000USD |
| Total Current Assets | 4,326,000USD | 13,657,000USD | 18,266,000USD | 21,873,000USD | 48,177,000USD | 16,326,000USD | 19,550,000USD | 21,775,000USD |
| Total Current Liabilities | 6,180,000USD | 5,749,000USD | 4,385,000USD | 3,384,000USD | 4,508,000USD | 3,960,000USD | 5,839,000USD | 5,370,000USD |
| Net Debt | -3,215,000USD | -12,865,000USD | -17,265,000USD | -5,161,000USD | -3,438,000USD | -6,659,000USD | -279,000USD | -5,293,000USD |
| Accounts Payable | 3,976,000USD | 911,000USD | 1,190,000USD | 1,720,000USD | 1,210,000USD | 1,596,000USD | 1,452,000USD | 1,731,000USD |
| Property Plant Equipment Net | 0USD | 1,000USD | 19,000USD | 110,000USD | 280,000USD | 15,000USD | 6,355,000USD | 7,290,000USD |
| Accumulated Other Comprehensive Income | -62,000USD | -18,000USD | -63,000USD | -48,000USD | -13,000USD | -2,000USD | 7,000USD | -5,000USD |
| Common Stock Shares Outstanding | 25,444,795shares | 17,938,000shares | 4,598,000shares | 4,539,000shares | 4,440,000shares | 17,433,350shares | — | — |
| Non Current Assets Total | 19,832,000USD | 55,583,000USD | 87,742,000USD | 134,000USD | 304,000USD | 15,000USD | 6,923,000USD | 8,537,000USD |
| Non Current Liabilities Total | 1,060,000USD | 9,099,000USD | 94,736,000USD | 0USD | 69,000USD | 219,000USD | 4,586,000USD | 5,342,000USD |
| Non Currrent Assets Other | 2,000USD | 2,000USD | 2,193,000USD | 24,000USD | 24,000USD | — | 568,000USD | 1,247,000USD |
| Net Working Capital | -1,854,000USD | 7,908,000USD | 13,881,000USD | 18,489,000USD | 43,669,000USD | 12,366,000USD | — | — |
| Unclassified Non Current Liabilities | 1,060,000USD | 8,822,000USD | 94,736,000USD | — | — | — | 4,586,000USD | 5,342,000USD |
| Unclassified Equity | 418,025,000USD | 405,594,000USD | 295,285,000USD | 291,274,000USD | 289,191,000USD | 231,368,000USD | 214,148,000USD | 188,083,000USD |
| Non Current Liabilities Other | — | 277,000USD | — | — | — | — | — | — |
| Short Term Debt | — | — | 48,000USD | 33,000USD | 93,000USD | 168,000USD | 446,000USD | — |
| Short Long Term Debt Total | — | — | 48,000USD | 33,000USD | 162,000USD | 387,000USD | 5,032,000USD | 5,342,000USD |
| Short Term Investments | — | — | 0USD | 16,048,000USD | 42,333,000USD | 6,759,000USD | 12,967,000USD | 10,060,000USD |
| Property Plant Equipment Gross | — | — | 377,000USD | 380,000USD | 492,000USD | 181,000USD | — | — |
| Short Long Term Debt | — | — | — | — | — | 168,000USD | — | — |
| Long Term Debt | — | — | — | — | — | 219,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 0USD |
| Stock Based Compensation | 320,000USD |
| Change To Liabilities | -262,000USD |
| Change In Working Capital | -1,003,000USD |
| Operating Cash Flow | -12,064,000USD |
| Investing Cash Flow | -35,073,000USD |
| Financing Cash Flow | 52,469,000USD |
| Effect Of Forex Changes On Cash | -5,000USD |
| Change In Cash | 5,327,000USD |
| End Cash Flow | 8,542,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -5,838,000USD | -31,967,000USD | -5,581,000USD | -6,822,000USD | -5,501,000USD | -40,981,000USD | -5,847,000USD | -8,942,000USD |
| Depreciation | 623,000USD | 0USD | 0USD | 1,000USD | 0USD | 0USD | 0USD | 4,000USD |
| Stock Based Compensation | 156,000USD | 257,000USD | 1,447,000USD | 256,000USD | 264,000USD | 133,000USD | 508,000USD | 326,000USD |
| Other Non Cash Items | 1,635,000USD | 29,462,000USD | 400,000USD | — | 37,000,000USD | 37,000,000USD | — | — |
| Change In Working Capital | 1,635,000USD | -260,000USD | 186,000USD | 147,000USD | -938,000USD | -964,000USD | 1,520,000USD | 223,000USD |
| Total Cash From Operating Activities | -3,424,000USD | -3,220,000USD | -3,548,000USD | -6,418,000USD | -6,175,000USD | -4,812,000USD | -3,819,000USD | -8,389,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -3,424,000USD | -3,220,000USD | -3,548,000USD | -6,418,000USD | -6,175,000USD | -4,812,000USD | -3,819,000USD | -8,389,000USD |
| Net Borrowings | 4,300,000USD | — | — | — | 0USD | — | — | — |
| Total Cash From Financing Activities | 4,654,000USD | 2,405,000USD | 1,900,000USD | 4,712,000USD | 738,000USD | 1,000USD | -446,000USD | 18,263,000USD |
| Issuance Of Capital Stock | 354,000USD | 1,452,000USD | 1,595,000USD | -370,000USD | 737,000USD | 0USD | -292,000USD | 10,937,000USD |
| Change In Cash | 1,230,000USD | -833,000USD | -1,674,000USD | -1,706,000USD | -5,437,000USD | -4,812,000USD | -4,265,000USD | 9,875,000USD |
| Begin Period Cash Flow | 3,215,000USD | 4,048,000USD | 5,722,000USD | 7,428,000USD | 12,865,000USD | 17,677,000USD | 21,942,000USD | 12,067,000USD |
| End Period Cash Flow | 4,445,000USD | 3,215,000USD | 4,048,000USD | 5,722,000USD | 7,428,000USD | 12,865,000USD | 17,677,000USD | 21,942,000USD |
| Other Cashflows From Financing Activities | 4,654,000USD | -1,900,000USD | 1,900,000USD | 5,082,000USD | 1,000USD | 1,000USD | -154,000USD | 7,326,000USD |
| Unclassified Operating Cash Flow | -1,635,000USD | — | — | — | -37,000,000USD | — | — | — |
| Unclassified Financing Cash Flow | -4,654,000USD | 2,853,000USD | -1,595,000USD | — | — | — | — | — |
| Investments | — | — | — | — | — | 0USD | 0USD | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -49,871,000USD | -62,883,000USD | -15,732,000USD | -27,329,000USD | -26,164,000USD | -21,157,000USD | -29,369,000USD | -31,547,000USD |
| Depreciation | 1,000USD | 63,000USD | 119,000USD | 169,000USD | 121,000USD | 163,000USD | 155,000USD | 218,000USD |
| Stock Based Compensation | 2,224,000USD | 1,117,000USD | 1,190,000USD | 2,083,000USD | 2,260,000USD | 1,893,000USD | 2,116,000USD | 3,280,000USD |
| Other Non Cash Items | 29,862,000USD | 37,000,000USD | -4,000USD | -208,000USD | -213,000USD | -95,000USD | -226,000USD | -253,000USD |
| Change In Working Capital | -865,000USD | 2,412,000USD | -5,381,000USD | 420,000USD | 242,000USD | -1,280,000USD | 850,000USD | 376,000USD |
| Total Cash From Operating Activities | -19,361,000USD | -22,291,000USD | -19,808,000USD | -24,865,000USD | -23,754,000USD | -20,476,000USD | -26,474,000USD | -27,926,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | -157,000USD | -5,000USD | -151,000USD | -4,423,000USD |
| Free Cash Flow | -19,361,000USD | -22,291,000USD | -19,808,000USD | -24,865,000USD | -23,911,000USD | -20,481,000USD | -26,625,000USD | -32,349,000USD |
| Total Cash From Financing Activities | 9,755,000USD | 17,818,000USD | 15,794,000USD | 0USD | 55,657,000USD | 15,800,000USD | 23,964,000USD | 2,515,000USD |
| Issuance Of Capital Stock | 3,414,000USD | 10,645,000USD | 0USD | 0USD | 55,583,000USD | 15,413,000USD | — | — |
| Change In Cash | -9,650,000USD | -4,473,000USD | 12,119,000USD | 1,594,000USD | -4,014,000USD | 1,735,000USD | -5,324,000USD | -723,000USD |
| Begin Period Cash Flow | 12,865,000USD | 17,338,000USD | 5,219,000USD | 3,625,000USD | 7,639,000USD | 5,904,000USD | 11,228,000USD | 11,951,000USD |
| End Period Cash Flow | 3,215,000USD | 12,865,000USD | 17,338,000USD | 5,219,000USD | 3,625,000USD | 7,639,000USD | 5,904,000USD | 11,228,000USD |
| Other Cashflows From Financing Activities | 9,755,000USD | 7,173,000USD | 15,794,000USD | — | 74,000USD | — | 165,000USD | 42,000USD |
| Unclassified Financing Cash Flow | -3,414,000USD | — | — | — | — | — | 23,799,000USD | 2,473,000USD |
| Investments | — | 0USD | 16,196,000USD | 26,459,000USD | -35,917,000USD | 6,411,000USD | — | — |
| Total Cashflows From Investing Activities | — | — | 16,196,000USD | 26,459,000USD | -35,917,000USD | 6,411,000USD | -2,814,000USD | 24,688,000USD |
| Other Cashflows From Investing Activities | — | — | 42,000USD | — | 66,000USD | 208,000USD | — | — |
| Net Borrowings | — | — | — | — | 0USD | — | — | — |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | -2,663,000USD | 29,111,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.